The Department of Public Health participates in research to improve services and care for the public. All research studies that involve human subjects must be reviewed by the Institutional Review Board (IRB) before and during the study.
The following studies require review by the IRB:
All research involving people receiving services directly from or funded by/through:
- Philadelphia Department of Behavioral Health and Intellectual disAbility Services (DBHIDS).
- Philadelphia Department of Human Services (with limited exclusions; please ask for guidance).
- Philadelphia Department of Public Health.
- Philadelphia Office of Homeless Services.
- Philadelphia Prison Health Services.
Also any research:
- Involving data, staff, or specimens from the Medical Examiner’s Office.
- Submitted with a request for review by other City departments.
This applies whether or not the study is a multi-site study.
The following studies also require review by the Health Commissioner’s Office Review Committee:
All research that:
- Involves Department of Public Health data.
- Involves people receiving services from the Department.
- Involves people receiving services funded by the Department.
- Will result in a publication or conference presentation involving the Department.
These studies must include an investigator or collaborator working for the Department of Public Health.
A study requires a Data License Agreement (DLA) from the Law Department if any of the following apply:
- The principal investigator or co-principal investigator (applicant) works at a non-City entity.
- The principal investigator or co-principal investigator (applicant) will share City data with any non-City entity.
- The principal investigator or co-principal investigator (applicant) intends to publish the results of the study.
The Law Department must approve all DLAs. Applicants should submit a request through the City’s privacy review portal. For questions about the process, contact HIPAAprivacy@phila.gov. Applicants should be prepared to provide an application to use City data for research and the documents listed below:
- Their IRB application materials.
- The IRB’s approval or waiver letter.
- A list of all data points or variables sought.
- A narrative description of the study (if not included with the IRB application materials).
- A letter of support from all City departments contributing data.
- Any state- or federal-level approvals, if necessary.
If a DLA is required, the Department of Public Health will not release data unless and until the DLA is fully executed.
Special regulations and requirements for research involving prisoners:
Research involving prisoners is subject to additional federal and state regulations and requirements. The Pennsylvania Criminal History Records Information Act (CHRIA) severely limits access to prisoner health records, even with the prisoner’s consent.
Researchers proposing studies involving prisoners or data about prisoners are urged to learn about these requirements. If the study will involve prisoners in City facilities, you must get approval from the Philadelphia Department of Prisons before applying for IRB approval.
Where and when
Most new studies that require IRB approval must be reviewed by the full committee at a regularly scheduled meeting. Minimal-risk studies that involve only materials collected for non-research purposes may be eligible for expedited review, and can be submitted at any time. Please review the requirements on the proposal submission application.
For studies requiring full review, application submission deadlines are generally two weeks before a scheduled meeting of the IRB.
|Application submission deadlines||Meeting schedule|
|May 20, 2022 – 3 p.m.
July 15, 2022 – 3 p.m.
September 16, 2022 – 3 p.m.
November 18, 2022 – 3 p.m.
|June 7, 2022
August 2, 2022
October 4, 2022
December 6, 2022
Meetings begin at 1 p.m. and are open to the public. Meetings are held virtually until further notice. Contact the IRB at IRB_submissions@phila.gov for information on attending a meeting.
Meeting dates may change without notice. Contact the IRB Office to confirm a meeting date: (215) 685-0869.
Investigators are encouraged to attend the IRB meetings at which their applications are reviewed.
Before your study begins
To submit a new study to the IRB, complete a proposal submission application. The application must include:
- An executive summary.
- Consent or assent forms.
- Materials for participant recruitment or distribution.
- The full research protocol or grant proposal.
- Any data collection instruments (surveys, measurement scales, etc.)
- The principal investigator’s conflict of interest form.
All consent and assent forms must adhere to informed consent requirements.
Investigators must also submit proof of human subjects research training taken within the last three years. City employees can access training through the City LMS. The course is listed as “PDPH IRB – NIH Human Subjects Training.” Investigators without access to this site can email the IRB office for a link to the course.
Managers of the City unit(s) involved must approve all studies. You may submit a unit approval form or a letter from the unit manager.
The PDPH IRB does not accept routine exclusion of potential research participants who do not speak English. Investigators must provide justification for exclusions based on language proficiency.
Please be sure to number the pages on all study documents for review.
You must inform all participants that they are being included in research, except for studies that qualify for a waiver. They must receive all pertinent information about that research and their rights. Please use or refer to the recommended template provided.
Please note that federal requirements for informed consent have changed for studies reviewed on or after January 21, 2019.
Waiver or alteration of informed consent and waiver of Health Insurance Portability and Accountability Act (HIPAA) authorization
Federal regulations allow limited human subjects research without written informed consent. An IRB may also approve a waiver of HIPAA authorization under specific situations. The Law Department’s HIPAA Privacy Unit will review HIPAA waiver requests. Refer to the summary information sheet for information on what waivers the IRB may permit. Complete section 5 of the proposal submission application, as appropriate. Be sure to provide justification for any requested waiver or alteration.
We recommend that you get a third party opinion from a children’s rights advocate when requesting waiver of parental consent for minors participating in research. This person should not be involved in the project. They should review the study requirements for the child and determine if there is any extra risk to the child by their participation without parental consent.
You should submit any requests for an exempt study determination with the proposal submission application. We recommend that you submit the exemption request at least two weeks before an application submission deadline. This allows time to make a full IRB study submission if the IRB determines that the study is not exempt.
Submitting revisions to an approved study:
The IRB will approve a study for a specific period of time (usually one year). During the period of your study, you may choose to submit revisions based on the study’s progress or other factors. Proposed revisions must be reviewed and approved before they go into effect.
Submitting a continuing review of an approved study:
All approved studies require a continuing review by the IRB. Investigators should submit update reports to the IRB between 20 to 60 days before the study is scheduled to expire.
Submitting a closure report:
Upon completion of an approved study, the principal investigator should submit a closure report to the IRB.